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August 16, 2005:730–42linical characteristics and testing results in those with and without
HF at the time of their AoD. Those with CHF tended to
resent in atypical fashion, and whereas CHF at the time of AoD
id not appear to lead to inordinate delays in patient presentation,
potential impact of CHF on time to recognition of AoD was
oted, and CHF was an independent predictor of surgical delay. In
ur data set, it is unclear whether these delays were due to clinician
reoccupation with CHF or the more subtle presentation of those
ith CHF and AoD.
Previous case reports have suggested that CHF in the presence
f AoD is due to aortic regurgitation from aortic valve disease,
ncomplete aortic leaflet closure (due to dilation of the sinotubular
unction), or aortic valve disruption (1,2,5). An additional mech-
nism of CHF at the time of AoD includes high-output heart
ailure (3,4,6). Although we confirm a high percentage of patients
ith CHF secondary to proximal aortic involvement, we also
emonstrated that as many as 20% of patients with CHF at the
ime of AoD had a distal dissection; consequently, in this consid-
rable minority, the mechanism of CHF must be something other
han direct aortic valve involvement by the dissection itself, such as
yocardial ischemia/infarction or hypertension. Delays in AoD
iagnosis and treatment are notable in our subjects; this may reflect
onsideration of diagnoses alternative to AoD, given the atypical
resentation in our subjects.
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disease. JAMA 2000;283:897–903.Heritability of Left Ventricular Mass and Other Morphologic Variables
orthern Manhattan Family Studyo the Editor: Left ventricular (LV) hypertrophy is a risk factor
or cardiovascular disease (1–3) and ischemic stroke (4–6). Cur-
ent data suggest that genetic factors and traditional cardiovascular
isk factors contribute to left ventricular mass (LVM) and LV
ypertrophy. Several studies demonstrated substantial genetic
ontribution to LVM in white, black, and American Indian
opulations (7–12). However, no data exist on heritability of LVM
n Hispanic patients.
Echocardiographically derived LVM has been validated by
omparison with autopsy data (13). From LVM and relative wall
hickness (RWT), three abnormal geometric patterns (i.e., con-
entric hypertrophy, eccentric hypertrophy, and concentric remod-
ling) (14) can be derived, and they appear to carry different risks
or cardiovascular events (6).
In the current study, we tested for the significance of heritability
or several LVM-related phenotypes in the high-risk Caribbean
ispanic families from the ongoing Northern Manhattan Family
tudy (NOMAFS). The detailed ascertainment scheme has been
escribed elsewhere (15). Transthoracic echocardiography was
erformed according to the guidelines of the American Society ofLVDD), left ventricular end-systolic diameter (LVSD), interven-
ricular septum (IVS), and posterior wall thickness (PWT) at end
iastole were measured. To minimize variability, we took mea-
urements in triplicate and averaged them.
Left ventricular mass was calculated from the corrected Amer-
can Society of Echocardiography method (13): LVM  0.8 (1.04
(LVDD  IVS  PWT)3  LVDD3])  0.6. Heritability of
VM also was assessed after correction for the indices of body size
ost commonly used in published reports: body surface area
LVM/BSA), height (LVM/HT), and height to the 2.7 power
LVM/HT2.7). The heritability of LVDD, LVSD, IVS, PWT,
nd RWT also was assessed. Relative wall thickness was calculated
ccording to two formulas: (IVS  PWT)/LVDD and 2 · PWT/
VDD (14). Echocardiographic studies were interpreted by re-
earchers who were blinded to the clinical characteristics. Interob-
erver variability ranged between 8% and 10%.
All the quantitative phenotypes were expressed as the mean and
tandard deviation. Log transformations were used for non-
ormally distributed variables. We used the Sequential Oligogenic
inkage Analysis Routines (SOLAR) package (Southwest Foun-
ation for Biomedical Research, San Antonio, Texas) (17) to
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August 16, 2005:730–42stimate heritability. Ascertainment correction was performed for
amilies that were enrolled based on probands’ LVM/BSA 75%.
The current study consisted of 623 subjects from 84 families.
he mean family size and age were 11 (range, 3 to 53) subjects and
7 (range, 18 to 95) years, respectively. Men comprised 37% of the
otal. Mean systolic blood pressure (SBP) was 122.1  19.8 mm
g. Mean body weight was 76 kg, and average height was 162 cm.
he prevalence of diabetes, hypertension, and antihypertensive
reatment was 14.2%, 40.6%, and 34.5%, respectively. Means and
tandard deviations of LV parameters are shown in Table 1. The
stimates of heritability for the nine LV phenotypes ranged from
.49 to 0.23 (all p values 0.001, except p  0.002 for LVDD)
fter adjusting for demographic and cardiovascular risk factors
Table 1). Left ventricular mass had the highest heritability and
VDD the lowest in model 3.
We calculated heritabilities for LVM and LV morphologic
arameters while adjusting for different combinations of covariates.
he results showed substantial heritabilities for all the phenotypes,
ith LVM having the strongest heritability. Age, gender, weight,
nd height accounted for the majority of interindividual variation
or LV phenotypes. Additional adjustment for SBP, diabetes, and
ntihypertensive medication almost yielded the same results. Sim-
lar to previous reports (12,18), our data showed weight as the most
mportant single predictor of LVM (explained 20% of LVM
ariance). Relative wall thickness showed weaker heritability than
VM, suggesting that LV geometry may be more strongly affected
y acquired conditions, such as blood pressure variability and other
nknown exposures. The age- and sex-adjusted heritability com-
rises common genes with pleiotropic effects on risk factors for LV
able 1. Heritability of LVM and Other Cardiac Morphologic V
Mean  SD Model 1
VM (g) 179.6  53.8 0.65
VM/BSA (g/m2) 99.5  25.0 0.50
VM/HT (g/m) 110.5  31.0 0.57
VM/HT2.7 48.8  13.8 0.48
WT (IVS  PWT)/LVDD 0.49  0.09 0.27
WT, 2PWT/LVDD 0.48  0.09 0.26
VDD (cm) 4.5  0.46 0.37
VSD (cm) 2.8  0.46 0.41
VS (cm) 1.1  0.21 0.41
WT (cm) 1.1  0.17 0.45
odel 1: adjusted for age and gender; model 2: adjusted for age, gender, weight, and
nd antihypertensive medication.
BSA  body surface area; HT  height; IVS  interventricular septum; LVDD
entricular end-systolic diameter; PWT  posterior wall thickness; RWT  relative
able 2. Heritability Estimates in the Recent Studies
Bella et al. (7)* Garner et al. (10)†
Ethnicity American Indian White
Data type Families Nuclear families
LVM 0.17 0.28
RWT 0.17 —
LVDD 0.33 —
LVSD — —
IVS 0.12 —
PWT 0.09 —
Adjusting for age, gender, research center, weight, height, systolic blood pressure, hear
lood pressure, weight, waist-hip ratio, and diabetes. §No adjustment for all paramet
.32 from sibling pairs, 0.30 from parent-child pairs, and 0.24 from second-degree relative
Abbreviations as in Table 1.henotypes, as well as unique genes for LV phenotypes. Further
djustment for other covariates helps remove the genetic factors
xerting pleiotropic effects on these known risk factors. The
ersistently significant heritabilities suggested a substantial genetic
nfluence on LV phenotypes. To our knowledge, no heritability
nformation was available in Hispanic patients, especially those of
aribbean origin. The present study suggests that genetic factors
ontributing to LVM and its related phenotypes may have similar
nd, possibly stronger, heritability in Caribbean Hispanic patients
s in other race-ethnic subgroups.
The Strong Heart Study (SHS) analyzed heritability in mostly
ibling data collected from 13 American Indian tribes in different
eographic locations (7). They reported significant but smaller
stimates of adjusted heritability than ours (Table 2). Dividing
heir participants into three SHS centers, Bella et al. (7) found no
ignificant heritability in relative pairs from Arizona. The SHS
nvestigators suspected that the Arizona Indians are a more
omogenous population, which may segregate fewer genetic poly-
orphisms influencing LV parameters. Using white twin pairs
ecruited from the general population, Swan et al. (8) reported
ubstantial unadjusted heritabilities of LVM and LV geometric
ata (Table 2). Adjustment for age, gender, blood pressure, and
eight reduced the estimate of heritability from 0.69 to 0.53 for
VM (no adjusted heritabilities for other parameters were re-
orted). Mayosi et al. (9) showed lower heritabilities in white
amilies ascertained through hypertensive probands (Table 2).
arner et al. (10) presented adjusted heritability of 0.28 for LVM
n white European nuclear families. Using the correlation between
elative pairs, Post et al. (12) estimated adjusted heritability of
les (n  623)
itability Variance Explained by Covariates
odel 2 Model 3 Model 1 Model 2 Model 3
.51 0.49 17% 38% 39%
.49 0.48 10% 13% 14%
.49 0.48 11% 30% 32%
.48 0.47 9% 31% 32%
.25 0.23 18% 20% 23%
.26 0.26 16% 18% 20%
.23 0.23 16% 28% 28%
.34 0.35 20% 24% 25%
.34 0.33 18% 28% 30%
.36 0.35 16% 27% 29%
t; model 3: adjusted for age, gender, weight, height, systolic blood pressure, diabetes,
eft ventricular end-diastolic diameter; LVM  left ventricular mass; LVSD  left
thickness.
Mayosi et al. (9)‡ Swan et al. (8)§ Post et al. (12)
White White White
Families Twins Relative pairs
0.23 0.69 0.24–0.32
— — —
0.19 0.61 —
— 0.27 —
0.17 0.34 —
0.06 0.61 —
medications, and diabetes. †Adjusting for weight. ‡Adjusting for age, gender, systolic
djusting for gender, age, height, weight, and systolic blood pressure: heritability wasariab
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August 16, 2005:730–42pproximately 0.30 for LVM in the Framingham Heart Study.
nalyzing data among hypertensive siblings, the HyperGEN
tudy found that African American subjects had higher sibling
orrelation in LVM compared with white subjects (11) but that
hite subjects had a higher correlation in RWT than did African
merican subjects. However, no heritability was presented in their
tudy.
Unlike most previous studies, we assessed the heritability of
VM after correction by the three most commonly used indices of
ody size. The estimates of heritability of LVM were not signif-
cantly affected by the type of indexing chosen, especially for model
, with the greatest number of covariates (Table 1). This observa-
ion suggests that no single body size index appears preferable in
tudies on adult populations similar to ours. Adjustment for
ovariates other than body size, age, and gender had almost no
nfluence on estimates of heritability in models 2 and 3.
More than 40% of our subjects were hypertensive, and 34.5%
ere taking antihypertensive medication. In our models, adjusting
or SBP and antihypertensive medication did not appreciably
nfluence the estimates of heritability after accounting for age,
ender, weight, and height. Furthermore, excluding all partici-
ants taking antihypertensive medications had little effect on
eritability estimations, although it yielded less significant p
alues (data not shown). Therefore, the effect of hypertension
nd antihypertensive medication may not be substantial in our
tudy.
In summary, our study indicated that significant genetic factors
nfluence the familial resemblance of LVM in the Caribbean
ispanic population. The considerable estimates of heritability
rovide the basis for our long-term goal of NOMAFS to map and
etect genetic variants contributing to LVM and its related
henotypes.
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etters to the Editor
atent Foramen Ovale/Atrial
eptal Defect Closure and Migraine:
earching the Rationale for the Procedure
zarbal et al. (1) studied closing patent foramen ovale (PFO) or
trial septal defect (ASD) for prophylaxis of migraine. The
ccompanying editorial highlights areas of caution (2). Additional
oncerns are: 1) Both right-to-left shunt (PFO) and left-to-right
hunt (ASD) appear associated with migraine (3). 2) Closure of
SD improves left ventricular stroke volume; this physiological
ariable (3) might be involved in precipitating daily migraines. 3)
